Michael J. Mcelhaugh - Net Worth and Insider Trading
Michael J. Mcelhaugh Net Worth
The estimated net worth of Michael J. Mcelhaugh is at least $5 Million dollars as of 2025-01-12. Michael J. Mcelhaugh is the Interim President & CEO of Arbutus Biopharma Corp and owns about 1,504,793 shares of Arbutus Biopharma Corp (ABUS) stock worth over $5 Million. Details can be seen in Michael J. Mcelhaugh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael J. Mcelhaugh has not made any transactions after 2024-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael J. Mcelhaugh
Michael J. Mcelhaugh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael J. Mcelhaugh owns 1 companies in total, including Arbutus Biopharma Corp (ABUS) .
Click here to see the complete history of Michael J. Mcelhaugh’s form 4 insider trades.
Insider Ownership Summary of Michael J. Mcelhaugh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2024-02-02 | Chief Business Officer |
Michael J. Mcelhaugh Latest Holdings Summary
Michael J. Mcelhaugh currently owns a total of 1 stock. Michael J. Mcelhaugh owns 1,504,793 shares of Arbutus Biopharma Corp (ABUS) as of February 2, 2024, with a value of $5 Million.
Latest Holdings of Michael J. Mcelhaugh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2024-02-02 | 1,504,793 | 3.29 | 4,950,769 |
Holding Weightings of Michael J. Mcelhaugh
Michael J. Mcelhaugh Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael J. Mcelhaugh has made a total of 4 transactions in Arbutus Biopharma Corp (ABUS) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Arbutus Biopharma Corp is the sale of 10,164 shares on February 2, 2024, which brought Michael J. Mcelhaugh around $23,479.
Insider Trading History of Michael J. Mcelhaugh
- 1
Michael J. Mcelhaugh Trading Performance
Michael J. Mcelhaugh Ownership Network
Ownership Network List of Michael J. Mcelhaugh
Ownership Network Relation of Michael J. Mcelhaugh
Michael J. Mcelhaugh Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Michael J. Mcelhaugh is the Chief Business Officer of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Scientific Officer Michael J. Sofia , and Chief Medical Officer Karen Sims .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Michael J. Mcelhaugh made 1 insider transaction in Arbutus Biopharma Corp (ABUS) with a net sale of 10,164. Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 9,982 shares made by Michael J. Sofia , a net sale of 9,593 shares made by David C Hastings , and a net sale of 8,846 shares made by Keith S Manchester .
In summary, during the past 3 months, insiders sold 0 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Michael J. Mcelhaugh Mailing Address
Above is the net worth, insider trading, and ownership report for Michael J. Mcelhaugh. You might contact Michael J. Mcelhaugh via mailing address: C/o Oncore Biopharma, Inc., 3805 Old Easton Road, Doylestown Pa 18902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
